BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28838264)

  • 21. PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL.
    Schachter-Tokarz E; Kelaidi C; Cassinat B; Chomienne C; Gardin C; Raffoux E; Dombret H; Fenaux P; Gallagher R
    Leukemia; 2010 Feb; 24(2):473-6. PubMed ID: 19865110
    [No Abstract]   [Full Text] [Related]  

  • 22. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
    Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RT-PCR in acute promyelocytic leukemia: second workshop of the European Retinoic Group, Paris, France, 17-18 December 1994.
    Leukemia; 1996 Feb; 10(2):368-71. PubMed ID: 8637250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.
    Iaccarino L; Ottone T; Divona M; Cicconi L; Cairoli R; Voso MT; Lo-Coco F
    Br J Haematol; 2016 Mar; 172(6):909-13. PubMed ID: 26728337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia.
    Dang DN; Morris HD; Feusner JH; Koduru P; Wilson K; Timmons CF; Cavalier M; Luu HS
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e546-8. PubMed ID: 24942021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
    Hecht A; Doll S; Altmann H; Nowak D; Lengfelder E; Röllig C; Ehninger G; Spiekermann K; Hiddemann W; Weiß C; Hofmann WK; Nolte F; Platzbecker U
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):889-896.e5. PubMed ID: 28923666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy.
    Liu M; Zhao X; Pan W; Qian Z; Du M; Wang LM; Huang H; Xiao H
    Br J Haematol; 2021 Oct; 195(2):e123-e128. PubMed ID: 34254314
    [No Abstract]   [Full Text] [Related]  

  • 31. The complex relationship of Tribbles pseudokinase 1, PML/RARA and C/EBPα in leukemia: two possible couples but not a trio.
    Velasco G
    Haematologica; 2016 Oct; 101(10):1129-1130. PubMed ID: 27694499
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
    Gao N; Wang XX; Sun JR; Yu WZ; Li XZ
    Ann Hematol; 2017 May; 96(5):711-718. PubMed ID: 28238096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified array-based comparative genomic hybridization detects cryptic and variant PML-RARA rearrangements in acute promyelocytic leukemia lacking classic translocations.
    Gruver AM; Rogers HJ; Cook JR; Ballif BC; Schultz RA; Batanian JR; Fesler MJ; Tubbs RR
    Diagn Mol Pathol; 2013 Mar; 22(1):10-21. PubMed ID: 23370423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
    Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
    Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilization of molecular phenotypes to detect relapse and optimize the management of acute promyelocytic leukemia.
    Hasan SK; Lo-Coco F
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10 Suppl 3():S139-43. PubMed ID: 21115433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
    de Thé H
    C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptic molecular lesion in acute promyelocytic leukemia with negative initial FISH.
    Singh J; Facey A; O'Malley F; Ryland GL; Blombery P; Gregory GP
    Leuk Lymphoma; 2021 Dec; 62(12):3060-3062. PubMed ID: 34151721
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
    Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
    Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.